Deficits in the Proline-Rich Synapse-Associated Shank3 Protein in Multiple Neuropsychiatric Disorders

Deficits in the Proline-Rich Synapse-Associated Shank3 Protein in Multiple Neuropsychiatric Disorders

Signaling between neurons in the human central nervous system (CNS) is accomplished through a highly interconnected network of presynaptic and postsynaptic elements essential in the conveyance of electrical and neurochemical information. One recently characterized core postsynaptic element essential...

Full description

Bibliographic Details
Main Authors:	Peter N. Alexandrov, Yuhai Zhao, Vivian Jaber, Lin Cong, Walter J. Lukiw
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-12-01
Series:	Frontiers in Neurology
Subjects:	5x familial Alzheimer’s disease transgenic mice 42 amino acid amyloid-beta peptides aluminum sulfate Alzheimer’s disease autism spectrum disorder bipolar disorder-schizophrenia
Online Access:	http://journal.frontiersin.org/article/10.3389/fneur.2017.00670/full

Similar Items

Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus
by: Yuhai Zhao, et al.
Published: (2017-07-01)

Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer’s Disease Brain
by: Yuhai Zhao, et al.
Published: (2017-09-01)

Lipopolysaccharide (LPS) Accumulates in Neocortical Neurons of Alzheimer’s Disease (AD) Brain and Impairs Transcription in Human Neuronal-Glial Primary Co-cultures
by: Yuhai Zhao, et al.
Published: (2017-12-01)

Microbiome-Derived Lipopolysaccharide (LPS) Selectively Inhibits Neurofilament Light Chain (NF-L) Gene Expression in Human Neuronal-Glial (HNG) Cells in Primary Culture
by: Walter J. Lukiw, et al.
Published: (2018-12-01)

Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease
by: Yuhai Zhao, et al.
Published: (2018-03-01)

microRNA-34a (miRNA-34a) Mediated Down-Regulation of the Post-synaptic Cytoskeletal Element SHANK3 in Sporadic Alzheimer's Disease (AD)
by: Yuhai Zhao, et al.
Published: (2019-02-01)

Down-Regulation of Essential Synaptic Components by GI-Tract Microbiome-Derived Lipopolysaccharide (LPS) in LPS-Treated Human Neuronal-Glial (HNG) Cells in Primary Culture: Relevance to Alzheimer’s Disease (AD)
by: Yuhai Zhao, et al.
Published: (2019-07-01)

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
by: Yuhai Zhao, et al.
Published: (2020-10-01)

Gastrointestinal (GI) Tract Microbiome-Derived Neurotoxins—Potent Neuro-Inflammatory Signals From the GI Tract via the Systemic Circulation Into the Brain
by: Walter J. Lukiw, et al.
Published: (2020-02-01)

Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (Aβ42) Peptide
by: Walter J. Lukiw, et al.
Published: (2019-12-01)

microRNA-146a Signaling in Alzheimer's Disease (AD) and Prion Disease (PrD)
by: Walter J. Lukiw, et al.
Published: (2020-06-01)

TREM2 signaling, miRNA-34a and the extinction of phagocytosis
by: Yuhai eZhao, et al.
Published: (2013-08-01)

Alzheimer’s disease (AD) as a disorder of the plasma membrane
by: Walter J. Lukiw
Published: (2013-02-01)

Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer’s disease
by: Walter J. Lukiw
Published: (2016-09-01)

Induction of the pro-inflammatory NF-kB-sensitive miRNA-146a by human neurotrophic viruses
by: James M. Hill, et al.
Published: (2015-02-01)

Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer’s Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7)
by: Yuhai Zhao, et al.
Published: (2016-12-01)

Circular RNA (circRNA) in Alzheimer’s disease (AD)
by: Walter eLukiw
Published: (2013-12-01)

Antagonism of NF-κB-up-regulated micro RNAs (miRNAs) in sporadic Alzheimer’s disease (AD) – anti-NF-κB versus anti-miRNA strategies
by: Walter eLukiw
Published: (2013-05-01)

Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer’s disease (AD)
by: Walter eLukiw
Published: (2013-08-01)

Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer’s disease brain
by: Yuhai Zhao, et al.
Published: (2021-10-01)

Alzheimer’s disease and the microbiome
by: Surjyadipta eBhattacharjee, et al.
Published: (2013-09-01)

Lipopolysaccharide-stimulated, NF-kB-, miRNA-146a- and miRNA-155-mediated molecular-genetic communication between the human gastrointestinal tract microbiome and the brain
by: Peter Alexandrov, et al.
Published: (2019-09-01)

Deficits in the miRNA-34a-regulated endogenous TREM2 phagocytosis sensor-receptor in Alzheimer’s disease (AD); an update
by: Surjyadipta eBhattacharjee, et al.
Published: (2014-06-01)

Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine
by: Walter J. Lukiw, et al.
Published: (2020-09-01)

Vesicular Transport of Encapsulated microRNA between Glial and Neuronal Cells
by: Walter J. Lukiw, et al.
Published: (2020-07-01)

Anti-microRNAs (AMs) as novel therapeutic agents in the clinical management of Alzheimer’s disease (AD)
by: Yuhai eZhao, et al.
Published: (2016-02-01)

Aluminum-induced amyloidogenesis and impairment in the clearance of amyloid peptides from the central nervous system (CNS) in Alzheimer’s disease (AD)
by: Yuhai eZhao, et al.
Published: (2014-09-01)

microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD)
by: Aileen I. Pogue, et al.
Published: (2021-08-01)

Microbial-generated amyloids and Alzheimer’s disease (AD)
by: James M Hill, et al.
Published: (2015-02-01)

Up-regulation of miRNA-146a in progressive, age-related inflammatory neurodegenerative disorders of the human CNS
by: Peter N. Alexandrov, et al.
Published: (2014-09-01)

MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer’s Disease (AD)-Novel and Unique Pathological Features
by: Yuhai Zhao, et al.
Published: (2015-12-01)

Opinion: an evaluation of progressive amyloidogenic and pro-inflammatory change in the primary visual cortex and retina in Alzheimer’s disease (AD)
by: James M Hill, et al.
Published: (2014-11-01)

microRNA-based biomarkers and the diagnosis of Alzheimer’s disease (AD)
by: Yuhai eZhao, et al.
Published: (2015-07-01)

Evolution and complexity of micro RNA (miRNA) in the human brain
by: Walter J. eLukiw BS, MS, PhD
Published: (2012-09-01)

Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration
by: Deidre J Devier, et al.
Published: (2015-03-01)

The gastrointestinal (GI) tract microbiome and potential link to Alzheimer’s disease (AD)
by: James M. Hill, et al.
Published: (2014-04-01)

Aluminum and its potential contribution to Alzheimer’s disease (AD)
by: Surjyadipta eBhattacharjee, et al.
Published: (2014-04-01)

microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection—A Commentary
by: Walter J. Lukiw
Published: (2021-06-01)

Pathogenic microbes, the microbiome, and Alzheimer's disease (AD)
by: James M Hill, et al.
Published: (2014-06-01)

Metal-Sulfate Induced Generation of ROS in Human Brain Cells: Detection Using an Isomeric Mixture of 5- and 6-Carboxy-2′,7′-Dichlorofluorescein Diacetate (Carboxy-DCFDA) as a Cell Permeant Tracer
by: Walter J. Lukiw, et al.
Published: (2012-08-01)